This paper is in the following e-collection/theme issue:

Telehealth and Telemonitoring (1679) Clinical Communication, Electronic Consultation and Telehealth (594) Digital Health, Telehealth and e-Innovation in Clinical Settings (405) Formative Evaluation of Digital Health Interventions (2425) mHealth for Telemedicine and Homecare (402)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/63661, first published .
Impact of Telehealth on Health Disparities Associated With Travel Time to Hospital for Patients With Recurrent Admissions: 4-Year Panel Data Analysis

Impact of Telehealth on Health Disparities Associated With Travel Time to Hospital for Patients With Recurrent Admissions: 4-Year Panel Data Analysis

Impact of Telehealth on Health Disparities Associated With Travel Time to Hospital for Patients With Recurrent Admissions: 4-Year Panel Data Analysis

Authors of this article:

Youyou Tao1 Author Orcid Image ;   Ace Vo1 Author Orcid Image ;   Dezhi Wu2 Author Orcid Image ;   Junyuan Lin1 Author Orcid Image ;   Kala Seal1 Author Orcid Image ;   Abhay Mishra3 Author Orcid Image ;   Arindam Brahma1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

    Original Paper

    1Loyola Marymount University, Los Angeles, CA, United States

    2University of South Carolina, Columbia, SC, United States

    3Iowa State University, Ames, IA, United States

    Corresponding Author:

    Youyou Tao, PhD

    Loyola Marymount University

    1 LMU Drive

    Los Angeles, CA, 90045

    United States

    Phone: 1 2069722430

    Email: youyou.tao@lmu.edu


    Background: Geographic, demographic, and socioeconomic differences in health outcomes persist despite the global focus on these issues by health organizations. Barriers to accessing care contribute significantly to these health disparities. Among these barriers, those related to travel time—the time required for patients to travel from their residences to health facilities—remain understudied compared with others.

    Objective: This study aimed to explore the impact of telehealth in addressing health disparities associated with travel time to hospitals for patients with recurrent hospital admissions. It specifically examined the role of telehealth in reducing in-hospital length of stay (LOS) for patients living farther from the hospital.

    Methods: We sourced the data from 4 datasets, and our final effective sample consisted of 1,600,699 admissions from 536,182 patients from 63 hospitals in New York and Florida in the United States from 2012 to 2015. We applied fixed-effect models to examine the direct effects and the interaction between telehealth and patients’ travel time to hospitals on LOS. We further conducted a series of robustness checks to validate our main models and performed post hoc analyses to explore the different effects of telehealth across various patient groups.

    Results: Our summary statistics show that, on average, 22.08% (353,396/1,600,699) of patients were admitted to a hospital with telehealth adopted, with an average LOS of 5.57 (SD 5.06) days and an average travel time of about 16.89 (SD 13.32) minutes. We found that telehealth adoption is associated with a reduced LOS (P<.001) and this effect is especially pronounced as the patients’ drive time to the hospital increases. Specifically, the coefficient for drive time is –0.0079 (P<.001), indicating that for every additional minute of driving time, there is a decrease of 0.0079 days (approximately 11 minutes) in the expected LOS. We also found that telehealth adoption has a larger impact on patients frequently needing health services, patients living in high internet coverage areas, and patients who have high virtualization potential diseases.

    Conclusions: Our findings suggest that telehealth adoption can mitigate certain health disparities for patients living farther from hospitals. This study provides key insights for health care practitioners and policy makers on telehealth’s role in addressing distance-related disparities and planning health care resources. It also has practical implications for hospitals in resource-limited countries that are in the early stages of implementing telehealth.

    J Med Internet Res 2024;26:e63661

    doi:10.2196/63661

    Keywords

    telehealth; health disparities; travel time; length of stay; recurrent admissions; health care access; virtualization potential; virtual care 


    The World Health Organization has stated that health services quality should not vary by factors such as ethnicity, gender, socioeconomic status, and geographic location [1]. Unfortunately, geographic, demographic, and socioeconomic differences exist in health outcomes despite the focus on such issues by health organizations worldwide [2,3]. Such disparities have adverse effects on particular groups, as evidenced by disproportionately worse medical outcomes [2,3]. The barriers to access care for these populations contribute to significant health disparities, defined as health differences related to economic, social, or environmental disadvantages [4]. Compared with other access barriers, access barriers related to travel time (ie, the time required for patients to travel from their residences to health facilities) remain understudied [5].

    This paper focuses on this particular access barrier, travel time. Previous studies found that travel time to the hospital can cause considerable health disparity [6,7]. Recent literature has explored the effect of travel time on patients’ in-hospital length of stay (LOS)—the number of days a patient stays in the hospital from admission to discharge—and found mixed results. For example, Simpson et al [8] found no difference in LOS based on travel time, while Jackson et al [9] discovered a positive association between these 2 variables. Rana et al [10] reported that the mean difference for LOS among patients with chronic obstructive pulmonary disease traveling short (0-15 km) and intermediate (>15-50 km) distances was statistically insignificant. However, patients traveling long distances (>50 km) had a significantly shorter LOS compared with both short- and intermediate-distance patients. This study suggested that this could be due to the distance decay phenomenon, where the interaction between 2 locations diminishes as the distance between them increases [10]. Specifically, patients who live farther from the hospital might experience a shorter LOS compared with those residing closer [10]. This distance decay phenomenon is also supported by other studies, which have shown that compared with patients living closer to health care facilities, those living farther away had worse health outcomes such as lower survival rates in hospitals and higher rates of nonattendance at follow-up due to the longer distance [6,7].

    While documenting the existence of health disparities that are associated with travel time to the hospital, scholars suggested that future studies should focus on examining how travel-related access barriers can cause adverse patient outcomes and further propose feasible interventions that could mitigate these health disparities [11]. Telehealth, defined as “the use of electronic information and telecommunication technologies to support long-distance clinical health care, patient and professional health-related education, health administration, and public health [12],” can help by providing virtual care that allows patients to manage their conditions and communicate with health care providers without traveling [13-15]. A 2022 report from the American Medical Association’s Physician Practice Benchmark Surveys shows that 74.4% of physicians reported using telehealth in their practice [16]. Telehealth is commonly used in specialties such as cardiology, emergency medicine, family medicine, hematology, general internal medicine, neurology, obstetrics and gynecology, oncology, and pediatrics [17]. However, even with the growing adoption of telehealth in clinical settings, the specific impact of telehealth on health outcomes related to travel time remains underexplored.

    Among various health outcome measures, our study aims to investigate how telehealth can reduce disparities in in-hospital LOS. Reducing LOS can not only alleviate the financial burden on patients but also contribute to the broader impact of decreasing societal health care costs [18]. Various health information technology (HIT) interventions, including telehealth, have been shown in the literature to statistically significantly reduce LOS [18-20]. Telehealth, in particular, has been shown to improve health outcomes, including LOS reduction, through two primary mechanisms: (1) real-time interventions that require real-time interaction between patients and their health providers, such as video conferencing, telephone communication, and telemonitoring equipment, facilitating immediate patient-provider interaction and timely care management [21-23], and (2) asynchronous interventions that do not require immediate interaction between patients and their health providers, including remote monitoring systems, interactive platforms, and in-home secure messaging through a patient portal using either a phone or a computer, which provide access to patient educational resources and enable continuous patient monitoring, with patients’ data reviewed at a later time for medical treatment [15,24-26]. Through these mechanisms, telehealth, alongside other HIT applications, plays a significant role in shortening LOS by enabling early intervention through the efficient gathering of useful information [27] and facilitating consultation, diagnosis, treatment, care management, education, and patients’ self-care [28]. Studies have shown that telehealth decreased LOS for patients in progressive care units without significant cost increases [29], for patients with vigorous chronic obstructive pulmonary disease after 7 months of monitoring [27], and for patients in rural and small hospitals through real-time telehealth interventions [30]. However, to the best of our knowledge, no study has specifically explored how telehealth could mitigate health disparities associated with travel time to hospitals in terms of LOS.

    Given the pressing need to address health disparities associated with travel time to hospitals, our study aims to comprehensively examine how health disparity in patients’ in-hospital LOS caused by long travel time to the hospital could be mitigated through telehealth implementation [27,29,30]. Our overarching research question is, “How can telehealth adopted by hospitals mitigate the adverse effects of travel time to the hospital, reduce health disparity, and influence patients’ health outcomes in terms of LOS?”


    We present the Methods section following the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines, and we also provided a checklist of items for the STROBE statement in Multimedia Appendix 1 [31].

    Study Design and Study Setting

    The data applied in this study were sourced from 4 sources. First, we used data from the Healthcare Cost and Utilization Project’s State Inpatient Databases (HCUP-SID) from 2012 to 2015 to obtain patient characteristics, admission, and clinical information [32]. The patient’s zip code information was part of this dataset. Second, we applied data from the American Hospital Association (AHA) annual surveys from 2012 to 2015 to obtain hospital characteristic data [33] including hospital location information such as latitude and longitude. Using this locational data and patient zip code, we computed “drive time to hospital” for each patient. Third, we used AHA’s information technology (IT) supplement files for 2011-2014 to obtain HIT implementation data [34]. Considering the lagged effects of HIT adoption, we followed the method that has been widely adopted to map the datasets with HIT variables lagged by 1 year [35]. Fourth, we collected additional census-based data, such as English proficiency level at the census tract level. We then matched the reference data between the census tracts and the United States Postal Service’s zip codes to allocate each census tract data proportionally.

    We merged data from the Healthcare Cost and Utilization Project (HCUP), AHA surveys, and AHA IT files with unique hospital identifications before merging the datasets with census data using patients’ zip codes from HCUP-SID. Furthermore, we filtered out data points beyond the 99th percentile for LOS, patient visit frequency, and travel time. To remove the outliers, we only included patients with an in-hospital stay of fewer than 35 days, fewer than 18 hospital visits over 4 years, and a travel time of less than 103.46 minutes in our sample data. To examine the effect of telehealth on recurrent hospital admissions, we only kept patients with 2 or more admissions in our sample. To ensure a consistent follow-up period for each patient, we excluded those whose first admission occurred in the dataset’s final year (2015), applying a 1-year cutoff for the follow-up duration. Our final effective sample consists of 1,600,699 admissions originating from 536,182 patients within 63 hospitals in New York and Florida in the United States from 2012 to 2015. This final dataset contains no missing values. Our data processing procedure is visualized in Figure 1. We chose datasets from New York and Florida because the high volume of hospital admissions in these 2 states and the availability of linkage variables that allowed us to connect patients with their hospital admissions so that we can examine telehealth’s impact on patients with recurrent admissions.

    ‎
    Figure 1. Data preparation method. AHA: American Hospital Association; freq.: frequency; HCUP-SID: Healthcare Cost and Utilization Project’s State Inpatient Datasets; IT: information technology; LOS: length of stay.

    Study Outcome

    We applied in-hospital LOS to investigate telehealth’s impact on patients’ health outcomes [20,36]. In-hospital LOS, measured as the number of days of hospital stays from admission to discharge, serves as a proxy for hospital operations efficiency measures [20,36].

    Study Variables

    Our main study variables were telehealth implementation and travel time to the hospital. We treated telehealth implementation in hospitals as a categorical variable, where 1 indicates telehealth is adopted by the hospital—meaning the hospital has a computerized system that supports telehealth—and 0 otherwise [33]. Telehealth implementation measured by this item includes health care services provided at a distance through various modalities such as remote monitoring, video conferencing, wireless communications, and electronic consults [37].

    Travel time to the hospital was calculated using the ArcGIS Network Analyst (Environmental Systems Research Institute) extension with the origin-destination cost matrix. The matrix provides both travel time and travel distance along the shortest route from the origins—patients’ locations, represented by the centroids of their zip codes—to the destinations, that is, hospitals’ physical addresses. To obtain travel time and travel distance, the origin-destination cost matrix was solved within ArcGIS Pro version 3.3.1 using the native Network Analyst solver. This solver is a subscription service from Environmental Systems Research Institute, which maintains and regularly updates the network solver. The process of obtaining drive time is as follows:

    1. Geocode (transforming text addressed to geospatial data point) the hospital addresses as points on the map, retaining hospital ID as identifiers
    2. Obtain New York and Florida zip code shapefiles from the census (which are equivalent to the United States Postal Service’s zip code)
    3. Convert the zip code shapefiles, which are polygons (spatial areas), to their respective centroids (midpoints of the polygons) as points on the map, retaining zip codes as identifiers
    4. Link patients’ zip codes to the respective points on the map. The points will serve as proxies of the actual patients’ addresses
    5. For each state (New York and Florida), assign the unique patients’ zip code locations as origins and hospital addresses as destinations, then calculate the origin-destination cost matrix to obtain pair-wise travel time and travel distance for each origin and destination
    6. Link the travel time and travel distance from the origin-destination cost matrix to the respective encounter data using patient zip codes and hospital IDs

    We also included community-level, hospital-level, patient-level, and admission-level variables as control variables to account for other factors that may influence in-hospital LOS. At the community level, we included the English proficiency level, measured by the percentage of the population that speaks English less than well in each zip code. Studies showed that compared with patients without a language barrier, patients with a language barrier experience more health care disparity in care, including longer LOS [38]. For patients to use telehealth services from home, the first requirement is to have internet access, and recent studies show that internet access can empower patients, influence health outcomes, and change their health service usage behaviors [39,40]. Thus, we also controlled the percentage of internet coverage at the zip code level.

    We applied hospital characteristics at the hospital level that may influence in-hospital LOS, such as hospital bed size, profit status, in a health system or not, and market share. Market share is measured by the Herfindahl-Hirschman Index. We also included HIT variables to control for the other HIT effects on LOS, which are clinical decision support system, computerized provider order entry, electronic clinical documentation, results viewing, and health information exchange (refer to Multimedia Appendix 2 for the detailed list of technologies and coding for HIT control variables).

    At the patient level, we included age at discharge, gender, and race. At the admission level, we included insurance types, including Medicare, Medicaid, and private insurance; the total number of comorbidities; chronic diagnoses; diagnoses; procedure; total charge at the current admission; the number of times the patient visited the hospitals since the first hospital visit; and the number of days between the current visit and the previous visit. We used 17 different types of body systems (refer to “Disease types” in Multimedia Appendix 3 for details) and a dummy variable that records whether the patient’s primary diagnosis is in the same body system at the current admission compared with the last admission. We presented the summary statistics of control variables and additional variables for post hoc analysis in Multimedia Appendix 3.

    Ethical Considerations

    The HCUP data used in this study are classified as a limited dataset, as defined by the HCUP website [41]. According to the website [41], “HCUP databases are limited data sets. HCUP databases conform to the definition of a limited data set. A limited data set is healthcare data in which 16 direct identifiers, specified in the Privacy Rule, have been removed. Under HIPAA, review by an institutional review board is not required for use of limited data sets.” The AHA’s annual surveys and IT supplement files used in this study were collected at the hospital level and did not involve human participants. This study was granted exemption from institutional review board review by Loyola Marymount University’s Institutional Review Board (LMU IRB 2024 FA12-R).

    Statistical Analysis

    After conducting descriptive analyses, we used STATA/SE 18.0 (StataCorp) for the subsequent data analysis. In this study, fixed-effect regression models were applied to assess the impact of telehealth on in-hospital LOS [42]. The model is specified in equations 1 and 2.

    LOSijtv = β0 + β1Telehealthj,t–1 + β2Drive_Timeijtv + Controlijtvη + λt + αv + γj + εitv (1)

    In equation 1, LOSijtv is the dependent variable that represents the in-hospital LOS for patient i’s vth hospital visit in hospital j at year t. Telehealthj,t–1 indicates whether telehealth was adopted by hospital j in the previous year (t−1). Drive_Timeijtv represents the drive time for patient i’s vth hospital visit to hospital j in year t. The focal parameters of interest in this model are β1 and β2, which capture the direct effect of telehealth implementation by hospital j in the previous year (t–1) and the direct effect of drive time for patient i to hospital j for the vth visit at year t. Controlijtv represents community-level, hospital-level, patient-level, and admission-level factors as described above that may influence patient in-hospital LOS. We include γj in the model to account for the hospital fixed effects that absorb unobserved hospital characteristics that do not vary over time, λt to absorb the change over time captured by the year fixed effect, αv to account for the fixed effects for hospital visit number that absorb the unobserved factors that could vary with each hospital visit, and εitv as the idiosyncratic error term.

    LOSijtv = β0 + β1Telehealthj,t–1 + β2Drive_Timeijtv + β3Telehealthj,t–1 × Drive_Timeijtv + Controlijtvη + λt + αv + γj + εitv (2)

    In equation 2, the focal parameter of interest is β3, which captures the interaction effect between telehealth and drive time to capture how the effect of telehealth on LOS varies with patients’ drive time to the hospital. In both models, robust SEs were applied to account for potential heteroskedasticity, and the errors were further clustered at the patient level to account for the possible within-patient correlations.


    Impact of Telehealth and Travel Time

    Table 1 presents summary statistics of our main variables. Our summary statistics show that, on average, 22.08% (353,396/1,600,699) of patients were admitted to a hospital with telehealth adopted, the average LOS was 5.57 (SD 5.06) days, and the average travel time was about 16.89 (SD 13.32) minutes.

    Table 1. Summary statistics for main variables.
    Variable nameVariable, mean (SD)Variable, minimumVariable, maximum
    Telehealtha0.22 (0.42)01
    Length of stay (in days)5.569 (5.06)034
    Travel time (in minutes)16.89 (13.32)0.89103.43

    aDummy variables with 2 values (ie, 0 and 1).

    To explore whether telehealth mitigates the effect of travel time to the hospital on patient in-hospital LOS, we first mapped the driving time to the hospital in minutes in Florida and New York in Figures 2A and 2B, respectively. From Figure 2, we observed that people with longer drive time to hospitals were distributed in both the north and south of Florida and on the edges of New York.

    ‎
    Figure 2. Travel time to hospital in minutes: (A) Florida and (B) New York.

    Next, we present our analysis result in Table 2. In Table 2, model 1, we can infer that both the direct effects of the implementation of telehealth and drive time are associated with a decreased LOS at the P<.001 level. Specifically, patients admitted to hospitals that have adopted telehealth services experience a reduction in in-hospital LOS by 0.0431 days (approximately 62 min) compared with those admitted to hospitals without telehealth implementation. Given the average hospital-adjusted expense per inpatient per day was US $3025 in the United States in 2022 [43], telehealth implementation can save around US $130.38 in hospital cost per patient stay.

    Table 2. Effect of telehealth adoption and drive time to hospital on length of staya,b.
    ModelsMain modelsRobustness check

    		Main effectInteraction effect addedComorbidities addedDynamic modelPatient-level FEc modelNBd modelLog (LOSe)PSMf

    		Model 1Model 2Model 3Model 4Model 5Model 6Model 7Model 8
    Telehealth

    		Coefficient–0.0431g0.00560.01030.00350.00920.00090.00560.0310

    		P value<.001.71.50.85.65.73.01.25

    		Robust SE0.010.020.020.020.020.0030.0020.03
    Drive time

    		Coefficient–0.0079–0.0073–0.0067–0.0060–0.0065–0.0009–0.0008–0.0057

    		P value<.001<.001<.001<.001<.001<.001<.001<.001

    		Robust SE0.0000.0000.0000.0000.0010.0000.0000.001
    Telehealth×Drive time

    		Coefficient—h–0.0026–0.0026–0.0029–0.0023–0.0003–0.0003–0.0023

    		P value—<.001<.001<.001.01<.001<.001.03

    		Robust SE—0.0010.0010.0000.0000.0000.0000.001
    LOSv–1i

    		Coefficient———0.0564————

    		P value———<.001————

    		Robust SE———0.001————
    Admission-level controlsYesYesYesYesYesYesYesYes
    Patient-level controlsYesYesYesYesYesYesYesYes
    Hospital-level controlsYesYesYesYesYesYesYesYes
    Community-level controlsYesYesYesYesYesYesYesYes
    Year and hospital fixed effectsYesYesYesYesYesYesYesYes
    ComorbiditiesNoNoYesNoNoNoNoNo
    Observations, n1,600,6991,600,6991,600,6991,070,9011,600,6991,600,6991,600,699542,089
    Patients, n536,182536,182536,182462,234536,182536,182536,182260,139
    Adjusted R20.5820.5820.5880.5940.569—0.4860.581

    aRobust SEs clustered by patients.

    bConstant is included in each of the models.

    cFE: fixed effect.

    dNB: negative binomial.

    eLOS: length of stay.

    fPSM: propensity score matching.

    gItalicized values represent [insert reason].

    hNot applicable.

    iLOSv–1: length of stay for patient’s v–1st visit to the hospital.

    From Table 2, model 1, we also found that the coefficient for drive time is –0.0079, with a P value <.001, indicating that longer drive times to the hospital are significantly associated with a slight decrease in LOS. For every additional minute of driving time, there is a decrease of 0.0079 days (approximately 11 min) in the expected LOS. From Table 2, model 2, we found that the interaction effect of the telehealth implementation and the drive time is associated with a decreased LOS at the P<.001 level, suggesting that telehealth may be particularly effective at reducing LOS for patients who live farther away from the hospital.

    To visualize the impact of telehealth adoption on the LOS for patients with various travel times to the hospital, we plotted this effect in the interaction plot in Figure 3. We plotted 2 separate lines, 1 for hospitals that implemented telehealth and 1 for those that did not. We found that for patients admitted to hospitals with telehealth, there is a steeper decrease in the LOS as the drive time increases from 0 to 100 minutes (indicated by the solid red line with triangle markers). Conversely, for patients admitted to hospitals without telehealth, the LOS decreases as the drive time increases, but the decrease is not as steep (indicated by the dashed blue line with square markers). This result indicates telehealth implementation is more effective in reducing LOS for patients who live farther from the hospital.

    ‎
    Figure 3. The impact of telehealth implementation on length of stay by drive time.

    To examine the robustness of our results, we conducted 5 sets of tests, the results of which are presented in Table 2, models 3-8. We first included an additional 29 types of comorbidities (refer to “Comorbidity type” in Multimedia Appendix 3 for more details) to control for the severity of the patient’s condition (result in model 3). Next, we incorporated the patients’ lagged LOS from the previous admission as an independent variable to account for the potential impact of past LOS on the current LOS (result in model 4). In our main models, we accounted for the hospital-level fixed effects but not the patient-level fixed effects. Accounting for hospital-level fixed effects allows us to absorb unobserved hospital characteristics that do not vary over time. However, by not including patient-level fixed effects, we may overlook unobserved patient characteristics that also do not vary over time. To address this in model 5, we considered patient-level fixed effects by introducing patient-specific intercepts in this model to control for unobserved, patient-specific characteristics that are time-invariant. We found the results from models 3-5 consistent with our main model.

    Furthermore, in our main model, we applied LOS as our dependent variable for better result interpretation. According to the literature, despite the right-skewness of LOS, linear regression is validated as statistically sound for large data samples, even when the dependent variable is not normally distributed [44-46]. The variance of the LOS is 25.66 days, which exceeds the mean of 5.57 days, indicating overdispersion in the data. To further test the robustness of our results, we applied a negative binomial model to account for skewness and over-dispersion (result in model 6). Furthermore, we examined the impact of telehealth adoption and drive time to the hospital on the logarithmically transformed LOS (result in model 7). We found the results from both models 6 and 7 to be consistent with our main model.

    In model 8, we used propensity score matching to construct a balanced comparison between the treatment group (ie, patients admitted to hospitals that have implemented telehealth) and the control group (ie, those admitted to hospitals without telehealth). We first calculated propensity scores using a logistic regression model with hospital-level factors (such as the implementation level of clinical decision support system, computerized provider order entry, electronic clinical documentation, results viewing, and health information exchange) and patient-level and admission-level (such as number of comorbidities, age, race, insurance type, current visit number, and body system categorizations). After matching patients using the k-nearest neighbors approach, we assessed the balance of hospital-level and patient-level variables between the treatment and control groups and found the standardized difference did not exceed a 10% threshold, indicating that treatment and control groups share similar statistical properties [47]. Postmatching analysis was conducted on the weighted and matched sample and clustered by patients to account for within-group correlations. The results, presented in model 8, are consistent with our main model. Overall, the results in models 3-8 show that our main results are robust and consistent among various robustness tests.

    Post Hoc Analysis

    To explore the nuanced effects of the direct effect of telehealth adoption and the interaction effects between telehealth adoption and drive time to hospital for subgroups of patients, we conducted post hoc analyses and present the result in Table 3. We first explored whether telehealth adoption has a larger impact on patients who need frequent hospital visits and have a high level of comorbidity by dividing the patients into groups 1 and 2 based on their frequency of hospital visits and comorbidity counts. Furthermore, we investigated whether telehealth adoption has a larger impact on patients living in areas with high internet coverage compared with those in areas with low coverage by dividing the patients into groups 3 and 4 based on median internet coverage. The literature suggests that internet coverage plays a significant role in delivery of various types of health care and broadband access is indeed a social determinant of health [48]. Access to broadband-based internet can allow specialists to collaborate with doctors in rural areas for saving patients with stroke or improving access to mental health care for the veterans [49]. These are a few examples of the myriad ways that internet access, particularly access to broadband internet, can serve as an enabler of delivery of telehealth across the population. In fact, research further indicates that a lack of broadband access can create a barrier for accessing telehealth services [50]. For our research, we surmise that while driving time itself can be a determinant for the level of use of telehealth services, there is a prerequisite of the presence of broadband within the community for accessing and using the telehealth services. In other words, the internet coverage itself would play a moderating role in determining the access and effectiveness of telehealth services (as measured by LOS) and we are trying to capture that in our post hoc analyses.

    Table 3. Post hoc patient group description.
    Post hoc patient groupVisit frequency (median=2)Inclusion conditionComorbidity (median=3)Internet coverage (median=80.04%)
    Group 1: High frequency and high comorbidity>2AND>3—a
    Group 2: Low frequency or low comorbidity≤2OR≤3—
    Group 3: High internet coverage———≥80.04%
    Group 4: Low internet coverage———<80.04%

    aNot applicable.

    In the subgroup analysis (Table 4), both the direct telehealth implementation effect and the interaction effects consistently reduce LOS for groups 1 and 2 (see the italicized results in Table 4), with a more pronounced effect for group 1, high frequency and high comorbidity group, indicating that telehealth could be effectively integrated into the care plans for patients who live farther from the hospitals, frequently engage with health care systems, and have complex health needs.

    Furthermore, we found that telehealth decreases LOS for the high internet coverage group (group 3) but not in the low internet coverage group (group 4). We also found that the interaction effects between telehealth and drive time are consistently associated with reduced LOS for both groups, but the effect size is larger for patients living in high internet coverage areas (see the italicized results in Table 4). This highlights the importance of high internet coverage as a prerequisite to fully benefit from telehealth.

    Table 4. Effect of telehealth adoption and drive time to hospital on length of stay by patient groupsa-d.
    Subgroup and effectsTelehealthDrive timeTelehealth×Drive timeObservations, n
    Group 1: High frequency and high comorbidity308,365

    		Direct effect


    		Coefficient–0.0844e–0.0051—f


    		P value.002<.001—


    		Robust SE0.030.001—

    		Interaction effects added


    		Coefficient–0.0093–0.0038–0.0044


    		P value.80<.001.009


    		Robust SE0.040.0010.002
    Group 2: Low frequency or low comorbidity1,292,334

    		Direct effect


    		Coefficient–0.0483–0.0082—


    		P value<.001<.001—


    		Robust SE0.010.000—

    		Interaction effects added





    		Coefficient–0.0000–0.0076–0.0025


    		P value.999<.001<.001


    		Robust SE0.020.0000.001
    Group 3: High internet coverage851,569

    		Direct effect


    		Coefficient–0.0500–0.0105—


    		P value.001<.001—


    		Robust SE0.020.000—

    		Interaction effects added


    		Coefficient0.0161–0.0095–0.0039


    		P value.42<.001<.001


    		Robust SE0.0200.0000.001
    Group 4: Low internet coverage749,130

    		Direct effect


    		Coefficient0.0095–0.0031—


    		P value.62<.001—


    		Robust SE0.020.001—

    		Interaction effects added


    		Coefficient0.0705–0.0024–0.0027


    		P value.008<.001.004


    		Robust SE0.030.0010.001

    aRobust SEs clustered by patients.

    bConstant is included in each of the models.

    cControl variables including community-level, hospital-level, patient-level, and admission-level are included in the models.

    dYear and hospital fixed effects are included in the models.

    eItalicized values represent [insert reason].

    fNot applicable.

    From Table 4, we found that telehealth adoption has a larger impact on groups 1 and 3. Thus, following these findings, in our next set of post hoc tests, we focus on these 2 patient groups and study the impact of telehealth adoption among patients with high versus low virtualization potential diseases, using a classification based on the degree of process virtualization [26]—where physical interactions between people and objects are replaced by virtual interactions. Telehealth is likely more effective among patients with diseases with high virtualization potential (DHVP) compared with those with diseases with low virtualization potential (DLVP) [26]. Based on the classification suggested by Ayabakan et al [26], we categorized patients into 2 groups—DHVP and DLVP. DHVP include endocrine, nutritional, and metabolic diseases, mental illnesses, diseases of the skin and subcutaneous tissue, and musculoskeletal system diseases. All other disease categories were classified as DLVP. Our results, as shown in Table 5, indicate that the direct impact of telehealth adoption is more effective in reducing LOS for patients with DHVP compared with those with DLVP. These findings underscore how the effectiveness of telehealth in reducing LOS is influenced by disease type.

    Table 5. Effect of telehealth adoption and drive time to hospital on length of stay by disease virtualization potentiala-d.
    GroupDirect effect of telehealthRobust SEP valueObservations, n
    Group 5: High frequency, high comorbidity, and DHVPe–0.1736f0.03.0239,361
    Group 6: High frequency, high comorbidity, and DLVPf–0.07310.03.01269,004
    Group 7: High internet coverage and DHVP–0.08250.04.04136,252
    Group 8: High internet coverage and DLVP–0.04910.02.001715,317

    aRobust SEs clustered by patients.

    bConstant is included in each of the models.

    cControl variables including community-level, hospital-level, patient-level, and admission-level are included in the models.

    dYear and hospital fixed effects are included in the models.

    eDHVP: diseases with high virtualization potential.

    fItalicized values represent [insert reason].

    gDLVP: diseases with low virtualization potential.


    Principal Findings

    Overall, this study is among the first to comprehensively examine how telehealth mitigates health disparities associated with travel time to hospital for patients with recurrent admissions using a large, inpatient, longitudinal dataset in the United States. We make 2 main contributions. First, our study contributes to the health disparity literature by identifying the important role of telehealth in mitigating health disparities generated by distance barriers for patients with recurrent admissions. Previous literature pointed out that distance barriers are associated with decreased health outcomes [6,7] and called for studies to identify evidence for interventions that mitigate these adverse effects [11,51]. Our study answers this call and finds evidence that telehealth plays a significant role in bridging health disparities generated by distance barriers. Our results contribute to the literature by providing further evidence of the direct effect of drive distance on LOS, showing that the relationship is statistically significant and negative. One possible explanation for this phenomenon is that longer drive times might encourage using telehealth to better discharge planning and care coordination after discharge to avoid waste of resources [52], which reduces the duration of hospital stays. Furthermore, our result indicates that telehealth could be particularly effective in reducing in-hospital LOS for patients who live farther away from hospitals, potentially leading to more efficient use of hospital resources and better patient outcomes.

    Second, our study examined the effects of telehealth on in-hospital LOS for patients with 2 or more admissions and various health conditions and diagnoses, thereby providing an in-depth understanding of the effects of telehealth. The result shows that telehealth adoption is not only associated with shortened in-hospital LOS but also reveals that the impact of telehealth is different for different patient groups. For example, telehealth has a larger impact on reducing in-hospital LOS for patients with complex health needs, needing frequent health services, and having DHVP. This may be due to telehealth facilitating better outpatient services [22,23] and medication management [53]. Such effects may be stronger for patients who frequently engage with health care systems and have complex health needs, potentially reducing their need for prolonged LOS further. Our results indicate telehealth could be effectively integrated into the care plans for those patient groups. Furthermore, the literature on how internet coverage influences the effects of telehealth on health outcomes is relatively sparse. Our study addresses this gap and finds that telehealth reduces in-hospital LOS for patients in high internet coverage areas and has no significant impact on those in low coverage areas. For patients living in high internet coverage areas, telehealth adoption is more effective for patients with DHVP. Future research should explore the underlying mechanisms of these findings.

    The research also has practical implications. First, it informs health care practitioners and hospitals that telehealth can benefit patients who require regular monitoring and intervention and need more resources, such as patients with frequent care use and many comorbidities. Second, this research offers policy makers evidence that telehealth can mitigate certain health disparities caused by distance barriers for patients with recurrent admissions. Third, our results highlight the importance of patients living in areas with high internet coverage in order to fully reap the benefits of telehealth. This is particularly important for rural residents, where internet services are limited. Several independent nonprofit research groups have repeatedly called for extending broadband access in rural communities to enable telehealth access [50,54,55]. Furthermore, the Federal Communications Commission has stated that broadband access is a “super determinant of health” [48], underscoring the importance of internet access and its impact on public health. Thus, we recommend decision makers consider the internet coverage factor when making telehealth implementation–related decisions. Fourth, our findings have practical implications for hospitals and policy makers in resource-limited countries that are beginning to adopt telehealth. For example, our data indicate that telehealth is more effective in reducing LOS for patients with frequent hospital visits, multiple comorbidities, those living far from medical facilities, and those with patients with DHVP. Hospitals serving such demographics are likely to benefit substantially from telehealth. Finally, the results of our study might encourage actionable process changes and software implementations for the providers leading to improved patient care, cost savings, and better resource use. We present a framework for such implementations and process changes in Figure 4. This would be particularly beneficial for providers with high rehospitalization rates and longer average LOS and patients with relatively long travel times to the health care facility. Some of the software and process changes we propose based on our findings in this research are to (1) incorporate additional data such as travel time and internet coverage data during admissions and patient intake process to the electronic health record system; (2) develop a data extraction module based on patient readmission rates, LOS, travel time, and internet coverage and apply analytics to identify patients with potential high telehealth impact; (3) develop promotional and incentivizing strategies to encourage enrollment and use of telehealth and integrate such strategies with patient reach out and communication channels; (4) integrate telehealth enrollment and use data with the electronic health record system (if not already integrated); and (5) develop analytics and predictive models for improved capacity planning, use, and cost savings.

    ‎
    Figure 4. Proposed process changes and software implementation framework. EHR: electronic health record; LOS: length of stay.

    Limitations and Future Research

    Our study has a few limitations that also present opportunities for future research. First, our study is limited to data from the states of New York and Florida from 2012 to 2015, when telehealth services were not as pervasive as today. Future research could investigate whether the effects of telehealth observed in this study are consistent across other US states with more recent longitudinal data. Second, due to the broad definition of telehealth in our dataset, it is challenging to pinpoint which specific telehealth interventions contribute to the observed outcomes. Future research should focus on differentiating the effects of various telehealth modalities to better understand how they address health care delivery challenges, particularly those related to travel-time barriers. Finally, our analysis focuses on hospital-level telehealth adoption, which, while comprehensive, may be too broad to inform specific decisions for particular health care settings or hospital units that provide various treatments for specific diseases or conditions. Future studies could further examine the impact of telehealth at the departmental level or within particular medical contexts.

    Conclusions

    Using a large panel dataset, this study contributes to the HIT and health disparity literature, providing strong empirical evidence that telehealth may mitigate certain health disparities generated by travel time–related barriers, with stronger effects for patients who visit hospitals more frequently, have a higher number of comorbidities, and live in high internet coverage area. Furthermore, it offers insights on guiding health care practitioners to allocate more resources to improve their telehealth access and service quality, especially for hospitals serving a large demographic of patients who live farther away from the hospital.

    Acknowledgments

    The authors are grateful to Le Family for their support on this study. This work was partially funded by the Le Family Endowed Faculty Opportunity Fund at the College of Business Administration, Loyola Marymount University, California, United States. This fund had no influence, either direct or indirect, on the outcomes or direction of the research.

    Data Availability

    Due to restricted usage imposed by the American Hospital Association (AHA) data use agreement and the Healthcare Cost and Utilization Project (HCUP) data use agreement, access to the datasets used in this study is limited. The dataset applied in this study can be accessed with permission from the AHA [33] and Agency for Healthcare Research and Quality [32].

    Authors' Contributions

    YT contributed to conceptualization, data curation, methodology, formal analysis, visualization, writing—original draft, and writing—review and editing. AV contributed to conceptualization, methodology, visualization, writing—original draft, and writing—review and editing. DW contributed to conceptualization, methodology, writing—original draft, and writing—review and editing. JL contributed to conceptualization, methodology, and writing—review and editing. KS contributed to conceptualization, methodology, and writing—review and editing. ANM contributed to methodology, project administration, and writing—review and editing. AB contributed to methodology, visualization, and writing—review and editing.

    Conflicts of Interest

    None declared.

    Multimedia Appendix 1

    Checklist of items for the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement.

    DOCX File , 22 KB
    Multimedia Appendix 2

    Health information technology items and coding.

    DOCX File , 17 KB
    Multimedia Appendix 3

    Summary statistics for control variables and additional variables.

    DOCX File , 26 KB
    1. Quality of care. World Health Organization. 2024. URL: https://www.who.int/health-topics/quality-of-care#tab=tab_1 [accessed 2024-03-23]
    2. Holmes L, Enwere M, Williams J, Ogundele B, Chavan P, Piccoli T, et al. Black-White risk differentials in COVID-19 (SARS-COV2) transmission, mortality and case fatality in the United States: translational epidemiologic perspective and challenges. Int J Environ Res Public Health. 2020;17(12):4322. [FREE Full text] [CrossRef] [Medline]
    3. Mohapatra S. Health inequity and health outcome: a causal linkage study of low and middle income countries. Qual Quant. Aug 27, 2016;51(6):2475-2488. [CrossRef]
    4. Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020: phase I report: recommendations for the framework and format of Healthy People 2020. U.S. Department of Health and Human Services. 2020. URL: https:/​/health.​gov/​our-work/​national-health-initiatives/​healthy-people/​healthy-people-2020/​secretarys-advisory-committee-2020 [accessed 2024-10-17]
    5. Labban M, Chen CR, Frego N, Nguyen DD, Lipsitz SR, Reich AJ, et al. Disparities in travel-related barriers to accessing health care from the 2017 National Household Travel Survey. JAMA Netw Open. Jul 03, 2023;6(7):e2325291. [FREE Full text] [CrossRef] [Medline]
    6. Kelly C, Hulme C, Farragher T, Clarke G. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open. Nov 24, 2016;6(11):e013059. [FREE Full text] [CrossRef] [Medline]
    7. Målqvist M, Sohel N, Do TT, Eriksson L, Persson LÅ. Distance decay in delivery care utilisation associated with neonatal mortality. A case referent study in northern Vietnam. BMC Public Health. Dec 13, 2010;10(1):762. [CrossRef] [Medline]
    8. Simpson RE, Wang CY, House MG, Zyromski NJ, Schmidt CM, Nakeeb A, et al. Travel distance affects rates and reasons for inpatient visits after pancreatectomy. HPB (Oxford). Jul 2019;21(7):818-826. [FREE Full text] [CrossRef] [Medline]
    9. Jackson KL, Glasgow RE, Mone MC, Sheng X, Mulvihill SJ, Scaife CL. Does travel distance influence length of stay in elective pancreatic surgery? HPB (Oxford). 2014;16(6):543-549. [FREE Full text] [CrossRef] [Medline]
    10. Rana R, Gow J, Moloney C, King A, Keijzers G, Beccaria G, et al. Does distance to hospital affect emergency department presentations and hospital length of stay among chronic obstructive pulmonary disease patients? Intern Med J. 2022;52(3):403-410. [CrossRef] [Medline]
    11. Turrentine FE, Buckley PJ, Sohn MW, Williams MD. Travel time influences readmission risk: geospatial mapping of surgical readmissions. Am Surg. 2017;83(6):573-582. [CrossRef] [Medline]
    12. What is telehealth? Health Resources & Services Administration. 2022. URL: https://www.hrsa.gov/rural-health/telehealth/what-is-telehealth [accessed 2024-03-27]
    13. Hirko KA, Kerver JM, Ford S, Szafranski C, Beckett J, Kitchen C, et al. Telehealth in response to the COVID-19 pandemic: implications for rural health disparities. J Am Med Inform Assoc. 2020;27(11):1816-1818. [FREE Full text] [CrossRef] [Medline]
    14. O’Connor M, Asdornwised U, Dempsey M, Huffenberger A, Jost S, Flynn D, et al. Using telehealth to reduce all-cause 30-day hospital readmissions among heart failure patients receiving skilled home health services. Appl Clin Inform. Dec 16, 2017;07(02):238-247. [CrossRef]
    15. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. Jun 21, 2012;344:e3874. [CrossRef] [Medline]
    16. Policy research perspectives. American Medical Association. 2022. URL: https://www.ama-assn.org/system/files/2022-prp-telehealth.pdf [accessed 2024-10-17]
    17. Harris Y, Goldwater J, Lloyd S, Tutty M, Mishra V. Future of health: advancing the appropriate use of telehealth within medical specialties. American Medical Association. 2024. URL: https://www.ama-assn.org/system/files/future-health-telehealth-use.pdf [accessed 2024-10-17]
    18. Baek H, Cho M, Kim S, Hwang H, Song M, Yoo S. Analysis of length of hospital stay using electronic health records: a statistical and data mining approach. PLoS One. 2018;13(4):e0195901. [CrossRef] [Medline]
    19. Singh R, Mathiassen L, Stachura ME, Astapova EV. Dynamic capabilities in home health: IT-enabled transformation of post-acute care. JAIS. 2011;12(2):163-188. [CrossRef]
    20. Oh JH, Zheng Z, Bardhan IR. Sooner or later? Health information technology, length of stay, and readmission risk. Production and Operations Management. Nov 01, 2018;27(11):2038-2053. [CrossRef]
    21. Morguet AJ, Kühnelt P, Kallel A, Jaster M, Schultheiss HP. Impact of telemedical care and monitoring on morbidity in mild to moderate chronic heart failure. Cardiology. 2008;111(2):134-139. [CrossRef] [Medline]
    22. Sammour Y, Spertus JA, Austin BA, Magalski A, Gupta SK, Shatla I, et al. Outpatient management of heart failure during the COVID-19 pandemic after adoption of a telehealth model. JACC Heart Fail. Dec 2021;9(12):916-924. [CrossRef] [Medline]
    23. Lieneck C, Weaver E, Maryon T. Outpatient telehealth implementation in the United States during the COVID-19 global pandemic: a systematic review. Medicina (Kaunas). May 09, 2021;57(5):462. [FREE Full text] [CrossRef] [Medline]
    24. Scherr D, Kastner P, Kollmann A, Hallas A, Auer J, Krappinger H, et al. Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial. J Med Internet Res. Aug 17, 2009;11(3):e34. [FREE Full text] [CrossRef] [Medline]
    25. Dendale P, de Keulenaer G, Troisfontaines P, Weytjens C, Mullens W, Elegeert I, et al. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) study. Eur J Heart Fail. Mar 2012;14(3):333-340. [FREE Full text] [CrossRef] [Medline]
    26. Ayabakan S, Bardhan IR, Zheng Z. Impact of telehealth and process virtualization on healthcare utilization. Information Systems Research. Mar 2024;35(1):45-65. [CrossRef]
    27. Segrelles Calvo G, Gómez-Suárez C, Soriano J, Zamora E, Gónzalez-Gamarra A, González-Béjar M, et al. A home telehealth program for patients with severe COPD: the PROMETE study. Respir Med. Mar 2014;108(3):453-462. [FREE Full text] [CrossRef] [Medline]
    28. Rodriguez JA, Saadi A, Schwamm LH, Bates DW, Samal L. Disparities in telehealth use among California patients with limited English proficiency. Health Aff (Millwood). Mar 2021;40(3):487-495. [CrossRef] [Medline]
    29. Armaignac DL, Saxena A, Rubens M, Valle CA, Williams LMS, Veledar E, et al. Impact of telemedicine on mortality, length of stay, and cost among patients in progressive care units: experience from a large healthcare system. Crit Care Med. May 2018;46(5):728-735. [FREE Full text] [CrossRef] [Medline]
    30. Gutierrez J, Moeckli J, Holcombe A, O'Shea AM, Bailey G, Rewerts K, et al. Implementing a telehospitalist program between Veterans Health Administration hospitals: outcomes, acceptance, and barriers to implementation. J Hosp Med. Mar 2021;16(3):156-163. [CrossRef] [Medline]
    31. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. Oct 20, 2007;370(9596):1453-1457. [FREE Full text] [CrossRef] [Medline]
    32. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality. 2024. URL: https://www.ahrq.gov/data/hcup/index.html [accessed 2024-10-30]
    33. AHA Annual Survey Database. American Hospital Association. 2024. URL: https://www.ahadata.com/aha-annual-survey-database [accessed 2024-04-30]
    34. AHA Annual Survey IT Database. American Hospital Association. 2024. URL: https://www.ahadata.com/aha-healthcare-it-database [accessed 2024-07-01]
    35. Lin YK, Lin M, Chen H. Do electronic health records affect quality of care? evidence from the HITECH Act. Information Systems Research. Mar 2019;30(1):306-318. [CrossRef]
    36. DesRoches CM, Campbell EG, Vogeli C, Zheng J, Rao SR, Shields AE, et al. Electronic health records' limited successes suggest more targeted uses. Health Aff (Millwood). Apr 2010;29(4):639-646. [CrossRef] [Medline]
    37. Fact sheet: telehealth. American Hospital Association. 2019. URL: https://www.aha.org/factsheet/telehealth [accessed 2024-10-17]
    38. John-Baptiste A, Naglie G, Tomlinson G, Alibhai SMH, Etchells E, Cheung A, et al. The effect of English language proficiency on length of stay and in-hospital mortality. J Gen Intern Med. Mar 2004;19(3):221-228. [CrossRef] [Medline]
    39. van Parys J, Brown ZY. Broadband internet access and health outcomes: patient and provider responses in Medicare. International Journal of Industrial Organization. Jul 2024;95:103072. [CrossRef]
    40. Duplaga M. The association between Internet use and health-related outcomes in older adults and the elderly: a cross-sectional study. BMC Med Inform Decis Mak. May 06, 2021;21(1):150. [FREE Full text] [CrossRef] [Medline]
    41. Healthcare Cost and Utilization Project data use agreement course. Agency for Healthcare Research and Quality. 2021. URL: https://hcup-us.ahrq.gov/DUA/dua_508/DUA508version.jsp [accessed 2024-10-17]
    42. Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA. MIT press; 2010.
    43. Hospital adjusted expenses per inpatient day. KFF. 2024. URL: https:/​/www.​kff.org/​health-costs/​state-indicator/​expenses-per-inpatient-day/​?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D [accessed 2024-10-16]
    44. Kim M, Holton M, Sweeting A, Koreshe E, McGeechan K, Miskovic-Wheatley J. Using health administrative data to model associations and predict hospital admissions and length of stay for people with eating disorders. BMC Psychiatry. May 10, 2023;23(1):326. [CrossRef] [Medline]
    45. Lumley T, Diehr P, Emerson S, Chen L. The importance of the normality assumption in large public health data sets. Annu Rev Public Health. 2002;23:151-169. [CrossRef] [Medline]
    46. Li X, Wong W, Lamoureux EL, Wong TY. Are linear regression techniques appropriate for analysis when the dependent (outcome) variable is not normally distributed? Invest Ophthalmol Vis Sci. May 01, 2012;53(6):3082-3083. [CrossRef] [Medline]
    47. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. May 2011;46(3):399-424. [CrossRef] [Medline]
    48. Advancing broadband connectivity as a social determinant of health. Federal Communications Commission. 2022. URL: https://www.fcc.gov/health/SDOH [accessed 2022-02-07]
    49. Commissioner Clyburn remarks on mapping broadband health. Federal Communications Commission. 2016. URL: https://www.fcc.gov/document/commissioner-clyburn-remarks-mapping-broadband-health [accessed 2024-10-17]
    50. ''Spotty at Best'': lack of rural broadband limits access to CARES Act telehealth services. American Telemedicine Association. 2020. URL: https:/​/www.​americantelemed.org/​ata-news/​spotty-at-best-lack-of-rural-broadband-limits-access-to-cares-act-telehealth-services/​ [accessed 2024-10-17]
    51. Chou S, Deily ME, Li S. Travel distance and health outcomes for scheduled surgery. Med Care. Mar 2014;52(3):250-257. [CrossRef] [Medline]
    52. Gu W, Fan N, Liao H. Evaluating readmission rates and discharge planning by analyzing the length-of-stay of patients. Ann Oper Res. Jun 28, 2018;276(1-2):89-108. [CrossRef]
    53. Badowski ME, Walker S, Bacchus S, Bartlett S, Chan J, Cochran KA, et al. Providing comprehensive medication management in telehealth. Pharmacotherapy. Mar 2018;38(2):e7-e16. [CrossRef] [Medline]
    54. Barriers to telehealth in rural areas. Rural Health Information Hub. 2023. URL: https://www.ruralhealthinfo.org/toolkits/telehealth/1/barriers [accessed 2024-10-17]
    55. AMA: equity must be baked into expansion of telehealth. American Medical Association. 2021. URL: https://www.ama-assn.org/press-center/press-releases/ama-equity-must-be-baked-expansion-telehealth [accessed 2021-06-21]

    ‎
    AHA: American Hospital Association
    DHVP: diseases with high virtualization potential
    DLVP: diseases with low virtualization potential
    HCUP: Healthcare Cost and Utilization Project
    HCUP-SID: Healthcare Cost and Utilization Project’s State Inpatient Datasets
    HIT: health information technology
    IT: information technology
    LOS: length of stay
    STROBE: Strengthening the Reporting of Observational Studies in Epidemiology

    Edited by G Eysenbach, N Cahill; submitted 26.06.24; peer-reviewed by EP Greenup, B Kragen; comments to author 26.07.24; revised version received 19.08.24; accepted 24.09.24; published 25.11.24.

    Copyright

    ©Youyou Tao, Ace Vo, Dezhi Wu, Junyuan Lin, Kala Seal, Abhay Mishra, Arindam Brahma. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 25.11.2024.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.